An intelligent peptide recognizes and traps Mycobacterium tuberculosis to inhibit macrophage phagocytosis

J Mater Chem B. 2022 Dec 22;11(1):180-187. doi: 10.1039/d2tb01764d.

Abstract

Tuberculosis is a major public health concern worldwide, and it is a serious threat to human health for a long period. Macrophage phagocytosis of Mycobacterium tuberculosis (M. tuberculosis) is a crucial process for granuloma formation, which shelters the bacteria and gives them an opportunity for re-activation and spread. Herein, we report an intelligent anti-microbial peptide that can recognize and trap the M. tuberculosis, inhibiting the macrophage phagocytosis process. The peptide (Bis-Pyrene-KLVFF-WHSGTPH, in abbreviation as BFH) first self-assembles into nanoparticles, and then forms nanofibers upon recognizing and binding M. tuberculosis. Subsequently, BFH traps M. tuberculosis by the in situ formed nanofibrous networks and the trapped M. tuberculosis are unable to invade host cells (macrophages). The intelligent anti-microbial peptide can significantly inhibit the phagocytosis of M. tuberculosis by macrophages, thereby providing a favorable theoretical basis for inhibiting the formation of tuberculosis granulomas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Macrophages / metabolism
  • Mycobacterium tuberculosis* / physiology
  • Peptides / metabolism
  • Peptides / pharmacology
  • Phagocytosis
  • Tuberculosis* / drug therapy
  • Tuberculosis* / metabolism
  • Tuberculosis* / microbiology

Substances

  • Peptides